Serigne Lo

Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy

Tuba N. Gide, Camelia Quek, Alexander M. Menzies et al. · Cancer Cell · 2019 · 980 citations · Full text

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study

Georgina V. Long, Victoria Atkinson, Serigne Lo et al. · The Lancet Oncology · 2018 · 975 citations

Neuro-oncology, Melanoma Brain Metastases, Medicine +8

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

Jeanne Tie, Joshua D. Cohen, Kamel Lahouel et al. · New England Journal of Medicine · 2022 · 884 citations · Full text

Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

Alexander M. Menzies, Rodabe N. Amaria, Elisa A. Rozeman et al. · Nature Medicine · 2021 · 408 citations

Surgical Oncology, Neoadjuvant Therapy, Medicine +8

Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma

Jenny Lee, Georgina V. Long, Stephanie Boyd et al. · Annals of Oncology · 2017 · 319 citations · Full text

Anti-pd1 Antibodies, Cancer Immunosurveillance, Oncology +10